Verdence Capital Advisors LLC lifted its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 8.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 48,659 shares of the company’s stock after purchasing an additional 3,825 shares during the period. Verdence Capital Advisors LLC’s holdings in Procter & Gamble were worth $7,069,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of Procter & Gamble during the second quarter worth approximately $27,862,105,000. State Street Corp raised its holdings in Procter & Gamble by 1.0% in the second quarter. State Street Corp now owns 102,216,308 shares of the company’s stock valued at $14,988,999,000 after acquiring an additional 965,461 shares in the last quarter. Bank of America Corp DE purchased a new position in Procter & Gamble in the second quarter worth approximately $3,850,628,000. Bank of New York Mellon Corp purchased a new position in Procter & Gamble in the second quarter worth approximately $2,281,505,000. Finally, Dimensional Fund Advisors LP grew its holdings in Procter & Gamble by 2.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock worth $1,704,182,000 after acquiring an additional 300,280 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Trading Down 0.7%
Shares of Procter & Gamble stock opened at $159.96 on Tuesday. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. The company has a fifty day simple moving average of $148.38 and a 200-day simple moving average of $148.47. The stock has a market cap of $370.75 billion, a price-to-earnings ratio of 24.09, a PEG ratio of 4.00 and a beta of 0.39. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The firm had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. During the same period last year, the business earned $1.99 EPS. Procter & Gamble’s revenue for the quarter was up 4.0% compared to the same quarter last year. On average, equities analysts forecast that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble’s payout ratio is 65.51%.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the stock. Sanford C. Bernstein reissued a “market perform” rating and issued a $149.00 price objective on shares of Procter & Gamble in a research report on Monday, August 24th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Procter & Gamble in a research report on Friday. Piper Sandler boosted their target price on shares of Procter & Gamble from $145.00 to $167.00 and gave the stock a “neutral” rating in a research note on Monday. Evercore upgraded shares of Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 target price for the company in a research note on Tuesday, October 6th. Finally, HSBC reissued a “hold” rating and issued a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. Fifteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $170.57.
Key Stories Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Exchange-traded funds purchased approximately $82.8 million of PG stock on October 22, indicating institutional demand and potentially providing support for the shares. ETFs Bought $82.8 Million of Procter & Gamble
- Positive Sentiment: Several analysts remain constructive: JPMorgan raised its price target, while TD Cowen, BNP Paribas Exane and Citigroup reportedly forecast further appreciation. Freedom Broker also upgraded PG to Buy. JPMorgan Price Target Increase TD Cowen Forecast
- Positive Sentiment: Investment commentary highlights PG’s strong household-product market shares and appeal as a high-yield, defensive dividend stock—factors that may attract income-oriented investors. High-Yield Dividend Stock Comparison
- Neutral Sentiment: Articles comparing PG with Colgate-Palmolive and discussing TIPS, Treasury bills and dividend stocks reinforce PG’s defensive and income-investment appeal, but provide limited new company-specific information. PG Versus CL
- Negative Sentiment: Higher oil prices could raise manufacturing, packaging, transportation and other costs. Unless offset by pricing or productivity gains, this would pressure PG’s margins and earnings outlook. Impact of Higher Oil Prices
- Negative Sentiment: Insiders reported notable selling: Shailesh Jejurikar sold 35,000 shares worth about $5.7 million, while other executives sold shares as well. These transactions are not necessarily bearish, but the reductions in ownership can create a modest sentiment overhang. SEC Insider Filing
Insider Buying and Selling at Procter & Gamble
In other news, CEO Paul Gama sold 4,331 shares of the stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $161.27, for a total value of $698,460.37. Following the completion of the sale, the chief executive officer directly owned 46,793 shares of the company’s stock, valued at approximately $7,546,307.11. This represents a 8.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Susan Whaley sold 2,369 shares of the stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $344,310.46. Following the sale, the insider owned 30,730 shares of the company’s stock, valued at approximately $4,466,298.20. This represents a 7.16% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 58,647 shares of company stock valued at $9,268,508. 0.23% of the stock is owned by insiders.
About Procter & Gamble
Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
See Also
- Five stocks we like better than Procter & Gamble
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
